Gregg A. Dean

2.4k total citations
80 papers, 1.9k citations indexed

About

Gregg A. Dean is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Gregg A. Dean has authored 80 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Virology, 31 papers in Immunology and 22 papers in Epidemiology. Recurrent topics in Gregg A. Dean's work include HIV Research and Treatment (33 papers), Virus-based gene therapy research (19 papers) and Immune Cell Function and Interaction (16 papers). Gregg A. Dean is often cited by papers focused on HIV Research and Treatment (33 papers), Virus-based gene therapy research (19 papers) and Immune Cell Function and Interaction (16 papers). Gregg A. Dean collaborates with scholars based in United States, Japan and Australia. Gregg A. Dean's co-authors include Alora LaVoy, Niels C. Pedersen, Mary Jo Burkhard, Peter F. Moore, Thierry Olivry, Gerhard H. Reubel, Shila K. Nordone, Edward A. Hoover, Ellen E. Sparger and Kristina E. Howard and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Journal of Virology.

In The Last Decade

Gregg A. Dean

80 papers receiving 1.9k citations

Peers

Countries citing papers authored by Gregg A. Dean

Since Specialization

Citations

This map shows the geographic impact of Gregg A. Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregg A. Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregg A. Dean more than expected).

Fields of papers citing papers by Gregg A. Dean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregg A. Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregg A. Dean. The network helps show where Gregg A. Dean may publish in the future.

Co-authorship network of co-authors of Gregg A. Dean

This figure shows the co-authorship network connecting the top 25 collaborators of Gregg A. Dean. A scholar is included among the top collaborators of Gregg A. Dean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregg A. Dean. Gregg A. Dean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Aptamer-Based Proteomic Analysis of Plasma from Cats (Felis catus) with Clinical Feline Infectious Peritonitis 2024 ·Viruses ·(unknown), Zaid Abdo, Barbara Graham, Alora LaVoy, Samantha Evans, Kelly S. Santangelo, Gregg A. Dean	1
2	Impact of oral probiotic Lactobacillus acidophilus vaccine strains on the immune response and gut microbiome of mice 2019 ·PLoS ONE ·Zaid Abdo, (unknown), Alora LaVoy, (unknown), Elizabeth P. Ryan, Gregg A. Dean	19
3	Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform 2018 ·PLoS ONE ·(unknown), Lin Zhang, Alora LaVoy, Barbara André, Chad Frank, Akinobu Kajikawa, Todd R. Klaenhammer, Gregg A. Dean	14
4	Correction: A Novel Candidate Vaccine for Cytauxzoonosis Inferred from Comparative Apicomplexan Genomics 2013 ·PLoS ONE ·Jaime L. Tarigo, Elizabeth H. Scholl, David M. Bird, Corrie C. Brown, Leah A. Cohn, Gregg A. Dean, Michael G. Levy, Denise L. Doolan, Angela Trieu, Shila K. Nordone, Philip L. Felgner, Adam Vigil, Adam J. Birkenheuer	13
5	TAK1 (MAP3K7) Signaling Regulates Hematopoietic Stem Cells through TNF-Dependent and -Independent Mechanisms 2012 ·PLoS ONE ·Giichi Takaesu, Maiko Inagaki, Keiyo Takubo, Yuji Mishina, Paul R. Hess, Gregg A. Dean, Akihiko Yoshimura, Kunihiro Matsumoto, Toshio Suda, Jun Ninomiya‐Tsuji	11
6	Partial Regulatory T Cell Depletion Prior to Acute Feline Immunodeficiency Virus Infection Does Not Alter Disease Pathogenesis 2011 ·PLoS ONE ·Susan Mikkelsen, Julie M. Long, Lin Zhang, (unknown), Sue VandeWoude, Gregg A. Dean	7
7	Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats 2010 ·Retrovirology ·Kristina E. Howard, Stacie Reckling, (unknown), Gregg A. Dean	11
8	In vivo depletion of CD4+CD25hi regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virus 2010 ·Virology ·Susan Mikkelsen, Stacie Reckling, (unknown), Gregg A. Dean	13
9	Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-α plasmids preserves global CD4 T lymphocyte function after challenge with FIV 2009 ·Vaccine ·(unknown), (unknown), Xiaoying Shen, (unknown), Gregg A. Dean, Ellen E. Sparger	7
10	Altered bone marrow dendritic cell cytokine production to toll‐like receptor and CD40 ligation during chronic feline immunodeficiency virus infection 2008 ·Immunology ·(unknown), Kevin P. O’Halloran, (unknown), (unknown), J. Campbell, Shila K. Nordone, Gregg A. Dean, Edward A. Hoover, P. Avery	9
11	Cloning of feline FOXP3 and detection of expression in CD4+CD25+ regulatory T cells 2007 ·Veterinary Immunology and Immunopathology ·(unknown), (unknown), Alora LaVoy, Stacie Reckling, W. A. F. Tompkins, Gregg A. Dean	31
12	Toll-like receptor expression in feline lymphoid tissues 2005 ·Veterinary Immunology and Immunopathology ·(unknown), Shila K. Nordone, Kristina E. Howard, Gregg A. Dean	38
13	Peptide mapping of feline immunodeficiency virus by IFN-γ ELISPOT 2004 ·Veterinary Immunology and Immunopathology ·Gregg A. Dean, Alora LaVoy, Mary Jo Burkhard	20
14	Cloning and expression of feline interleukin 15 2004 ·Cytokine ·Gregg A. Dean, Anne M. Barger, Alora LaVoy	8
15	Evaluation of BioStar® FLU OIA® assay for rapid detection of influenza A and B viruses in respiratory specimens 2000 ·Journal of Clinical Virology ·Musa Hindiyeh, Carol Goulding, H. R. Morgan, (unknown), Janine Langer, Linda M. Fox, Gregg A. Dean, (unknown), (unknown), (unknown), Sepehr Shakib, (unknown), Ann M. Powers, (unknown), Marion Johnson, (unknown), Karen C. Carroll	36
16	Investigation of Recombinant Human Insulin-Like Growth Factor Type I in Thymus Regeneration in the Acute Stage of Experimental FIV Infection in Juvenile Cats 1999 ·AIDS Research and Human Retroviruses ·Jennifer Woo, Gregg A. Dean, Alora LaVoy, Ross Clark, Peter F. Moore	16
17	Workshop Summary : Lessons from the Cat: Feline Immunodeficiency Virus as a Tool to Develop Intervention Strategies against Human Immunodeficiency Virus Type 1 1998 ·AIDS Research and Human Retroviruses ·John H. Elder, Gregg A. Dean, Edward A. Hoover, James A. Hoxie, Michael H. Malim, (unknown), James C. Neil, (unknown), Ellen E. Sparger, Mary B. Tompkins, W. A. F. Tompkins, (unknown), Naoya Yuhki, (unknown), R.H. Miller	57
18	Listeria monocytogenes and Serratia marcescens infections as models for Th1/Th2 immunity in laboratory cats 1998 ·Veterinary Immunology and Immunopathology ·N. C. Pedersen, Gregg A. Dean, (unknown), Antti Sukura, J. Higgins	17
19	Cloning, expression and characterization of biologically active feline tumour necrosis factor-α 1995 ·Veterinary Immunology and Immunopathology ·Espen Rimstad, Gerhard H. Reubel, Gregg A. Dean, Joanne Higgins, Niels C. Pedersen	19
20	Early Pathogenesis of Disease Caused by SIVsmmPBjl4 Molecular Clone 1.9 in Macaques 1993 ·AIDS Research and Human Retroviruses ·Zimra R. Israel, Gregg A. Dean, Donald H. Maul, Shawn P. O’Neil, (unknown), (unknown), Patricia N. Fultz, Edward A. Hoover	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact